94 related articles for article (PubMed ID: 20925433)
1. Toward the development of innovative bifunctional agents to induce differentiation and to promote apoptosis in leukemia: clinical candidates and perspectives.
Vizirianakis IS; Chatzopoulou M; Bonovolias ID; Nicolaou I; Demopoulos VJ; Tsiftsoglou AS
J Med Chem; 2010 Oct; 53(19):6779-810. PubMed ID: 20925433
[No Abstract] [Full Text] [Related]
2. Chemotherapy resistance of glioblastoma stem cells.
Eramo A; Ricci-Vitiani L; Zeuner A; Pallini R; Lotti F; Sette G; Pilozzi E; Larocca LM; Peschle C; De Maria R
Cell Death Differ; 2006 Jul; 13(7):1238-41. PubMed ID: 16456578
[No Abstract] [Full Text] [Related]
3. Induction of tumor cell differentiation as a therapeutic approach: preclinical models for hematopoietic and solid neoplasms.
Reiss M; Gamba-Vitalo C; Sartorelli AC
Cancer Treat Rep; 1986 Jan; 70(1):201-18. PubMed ID: 3510735
[No Abstract] [Full Text] [Related]
4. Multilevel targeting of hematopoietic stem cell self-renewal, differentiation and apoptosis for leukemia therapy.
Tsiftsoglou AS; Bonovolias ID; Tsiftsoglou SA
Pharmacol Ther; 2009 Jun; 122(3):264-80. PubMed ID: 19306896
[TBL] [Abstract][Full Text] [Related]
5. New targets for cancer chemotherapy.
Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA
Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208
[No Abstract] [Full Text] [Related]
6. Synthesis of furopyrazole analogs of 1-benzyl-3-(5-hydroxymethyl-2-furyl)indazole (YC-1) as novel anti-leukemia agents.
Chou LC; Huang LJ; Yang JS; Lee FY; Teng CM; Kuo SC
Bioorg Med Chem; 2007 Feb; 15(4):1732-40. PubMed ID: 17189698
[TBL] [Abstract][Full Text] [Related]
7. Antimultidrug-resistant effect and mechanism of a novel CA-4 analogue MZ3 on leukemia cells.
Xu D; Fang L; Zhu Q; Hu Y; He Q; Yang B
Pharmazie; 2008 Jul; 63(7):528-33. PubMed ID: 18717489
[TBL] [Abstract][Full Text] [Related]
8. The leukemia stem cell.
Estrov Z
Cancer Treat Res; 2010; 145():1-17. PubMed ID: 20306242
[No Abstract] [Full Text] [Related]
9. Quantitative approaches to analyzing imatinib-treated chronic myeloid leukemia.
Michor F
Trends Pharmacol Sci; 2007 May; 28(5):197-9. PubMed ID: 17412430
[TBL] [Abstract][Full Text] [Related]
10. Properties of antileukaemic drugs.
Brusamolino E
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():30-3. PubMed ID: 2653515
[No Abstract] [Full Text] [Related]
11. Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells.
Castro-Galache MD; Menéndez-Gutiérrez MP; Carrasco Garcia E; Garcia-Morales P; Martinez-Lacaci I; Saceda M; Ferragut JA
Int J Biochem Cell Biol; 2007; 39(10):1877-85. PubMed ID: 17588800
[TBL] [Abstract][Full Text] [Related]
12. Have chemosensitizing strategies for multidrug-resistant childhood acute lymphoblastic leukemia come of age?
Bourquin JP; Bornhauser B
Expert Rev Hematol; 2010 Aug; 3(4):369-72. PubMed ID: 21083025
[No Abstract] [Full Text] [Related]
13. Apoptosis induction with purine analogs on freshly isolated chronic myeloid leukemia cells.
Zinzani PL; Martinelli G; Buzzi M; Farabegoli P; Bendandi M; Tura S
Haematologica; 1995; 80(4):390-1. PubMed ID: 7590510
[No Abstract] [Full Text] [Related]
14. Mathematical models of cancer stem cells.
Michor F
J Clin Oncol; 2008 Jun; 26(17):2854-61. PubMed ID: 18539964
[TBL] [Abstract][Full Text] [Related]
15. Natural triterpenoids from Cecropia lyratiloba are cytotoxic to both sensitive and multidrug resistant leukemia cell lines.
Rocha Gda G; Simões M; Lúcio KA; Oliveira RR; Coelho Kaplan MA; Gattass CR
Bioorg Med Chem; 2007 Dec; 15(23):7355-60. PubMed ID: 17889544
[TBL] [Abstract][Full Text] [Related]
16. Leukemic cell maturation.
Ross DW
Arch Pathol Lab Med; 1985 Apr; 109(4):309-13. PubMed ID: 3885897
[TBL] [Abstract][Full Text] [Related]
17. Molecular pharmacodynamics in childhood leukemia.
Pieters R; den Boer ML
Int J Hematol; 2003 Dec; 78(5):402-13. PubMed ID: 14704032
[No Abstract] [Full Text] [Related]
18. All-trans retinoic acid might also induce apoptosis in freshly isolated chronic myeloid leukemia cells.
Stagno F; Consoli U; Cacciola E
Haematologica; 1997; 82(1):125. PubMed ID: 9107100
[No Abstract] [Full Text] [Related]
19. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
20. [Multidrug resistance].
Baccarani M
Haematologica; 1991 Jun; 76 Suppl 3():145-9. PubMed ID: 1684337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
